THANK YOU TO ALL OUR DONORS!

DNDi would like to thank its donors worldwide for their loyal commitment and collaboration since 2003. DNDi is grateful for the support received from all the donors, who contributed toward the advancement of its mission and goals. Read more about our key financial figures

Listed are supporters who have given a cumulative contribution in excess of USD or EUR 10,000 as well as collaborative funding partners.

 

PUBLIC INSTITUTIONAL DONORS

AUSTRALIA

Australian Trade and Investment Commission (Austrade)

www.austrade.gov.au

• Grant period: 2016-2018
• Support to joint DNDi – Epichem Pty Ltd project – Novel compounds for the treatment of leishmaniasis in humans and animals
• Total amount: AUSD 250,000
• Link to announcement

BRAZIL

Banco Nacional de Desenvolvimento Econômico e Social (BNDES)

www.bndes.gov.br

• Grant period: 2016-2018
• Support to DNDi initiative, Lead Optimization Latin America – LOLA, and also to the Chagas Clinical Research Platform and the Network of Investigators and Collaborators in Leishmaniasis – redLEISH
• Total amount: EUR 1 million

Fundação Oswaldo Cruz (Fiocruz)

https://portal.fiocruz.br

• Grant period: 2016-2018
• Support to DNDi initiative, Lead Optimization Latin America – LOLA, and to the Chagas Clinical Research Platform and the Network of Investigators and Collaborators in Leishmaniasis – redLEISH
• Total amount: EUR 100,000

• Support period:  2003-2012
• Support to DNDi initiative
• Collaborative funding

Ministry of Health

portalms.saude.gov.br

• Grant period: 2013-2015
• Support to DNDi initiative, Chagas disease & Leishmaniasis
• Total amount: BRL 995,000 (EUR 324,900)

Science and Technology Innovation Agency  (Finep) / Through the Regional and National Finep Awards for Innovation in Social Technology

www.finep.gov.br

• Grant period: 2015
• Support to DNDi’ s activities through the “Award for Innovation in Social Technology”
• Total amount: EUR 67,000
• Link to press release

CANADA

International Development Research Centre (IDRC)

www.idrc.ca

• Grant period: 2017-2019
• Support to alliances for Chagas elimination in Central America
• Total amount: CAD 170,000

COLOMBIA

Ruta-N / City of Medellin

 www.rutanmedellin.org

• Grant period: 2015-2016
• Support to DNDi cutaneous leishmaniasis programme (Anfoleish)
• Total amount: USD 317,500 (EUR 269,365)
• Link to press release

EUROPE

European and Developing Countries Clinical Trials Partnership Association (EDCTP2 Programme)

 www.edctp.org

• Grant period: 2017-2020
• Support to Afri-KA-DIA, towards an adapted, safe, effective combination treatment for African visceral leishmaniasis and improved diagnostic tools
• Total amount: EUR 5,560,784
• Link to press release

• Grant period: 2010-2014
• Support to clinical studies for the assessment of the fixed-dose combination of ASMQ as an alternative antimalarial treatment for children in Africa
• Total amount: EUR 577,900

European Union – Framework Programme 5 and 6

• Grant period: 2004-2006 / 2006-2009
• Support to DNDi malaria project (FACT) / to the Human African Trypanosomiasis Platform
• Total amount: EUR 241,300 / EUR 340,000
• cordis.europa.eu/inco/

European Union – Framework Programme 7

• Grant period: 2013-2016
• Support to AfriCoLeish – Development of a care package for treatment and control of visceral leishmaniasis in East Africa
• Total amount: EUR 3 million
• Link to initial press release 
www.africoleish.org
• cordis.europa.eu/projects/

• Grant period: 2009-2012
• Support to LEISHDNAVAX – Development of a DNA vaccine for visceral leishmaniasis
• Total amount: EUR 253,800
ec.europa.eu/research/health/

FRANCE

French Development Agency (AFD)

www.afd.fr

• Grant period: 2015-2018
• Support to specific projects on visceral leishmaniasis in Africa
• Total amount: EUR 2 million
• Link to press release

• Grant period: 2012-2017
• Support to specific projects in Africa: technology transfer of ASAQ for Malaria, clinical trials for ASMQ (Malaria), development of a new oral treatment for human African trypanosomiasis (HAT), support to the HAT Platform and development of a new paediatric formulation of HIV
• Total amount: EUR 5 million

• Grant period: 2006-2010
• Support to DNDi malaria project (FACT)
• Total amount: EUR 2 million
• Link to initial press release

Ministry of European and Foreign Affairs (MEAE)

www.diplomatie.gouv.fr

• Grant period: 2009-2011
• Support to specific discovery and lead optimisation projects for human African trypanosomiasis, Chagas disease, and leishmaniasis
• Total amount: EUR 1.3 million

• Grant period: 2007-2010
• Support DNDi’s disease programmes for human African trypanosomiasis and visceral leishmaniasis in Africa (preclinical, clinical and implementation activities and capacity building.)
• Total amount: EUR 5.9 million

GERMANY

Federal Ministry of Education and Research (BMBF) through KfW

www.bmbf.de

• Grant period: 2016-2021
• Support to DNDi’s development of products for the prevention, diagnosis and treatment of neglected and poverty-related diseases
• Total amount: EUR 10 million
• Link to press release

• Grant period: 2011-2015
• Support to DNDi’s disease programmes for human African trypanosomiasis, Chagas disease, leishmaniasis and filarial diseases (from screening to clinical studies for new and improved products as well as capacity strengthening activities through the disease platforms)
• Total amount: EUR 9.1 million (including supplemental of EUR 1.1 million for 2015)
• Link to press release

Federal Ministry of Health

www.bundesgesundheitsministerium.de

• Grant period: 2017-2018
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: EUR 1,350,000

• Grant period: 2017
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: EUR 750,000

• Grant period: 2016-2017
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: EUR 500,000
• Link to press release

German International Cooperation (GIZ) on behalf of the Government of the Federal Republic of Germany

www.giz.de

• Grant period: 2008-2009
• Support to specific discovery, preclinical/clinical projects (screening, lead optimization for Chagas disease, Fexinidazole for human African trypanosomiasis)
• Total amount: EUR 1 million

INTERNATIONAL

The Global Fund to fight AIDS, Tuberculosis and Malaria

www.theglobalfund.org

• Grant period: 2010-2012
• Support to the baseline and endpoint survey work for the independent evaluation of phase 1 of the Affordable Medicines Facility – malaria (AMFm) in Ghana
• Total amount: EUR 532,800

Unitaid

www.unitaid.eu

• Grant period: 2013-2017
• Total amount: USD 17.3 million
• Support to the development of child-adapted antiretroviral (ARV) formulation
• Link to press release

World Health Organization – Special Programme for Research and Training in Tropical Diseases (WHO-TDR)

www.who.int/tdr/

• Grant period: 2017-2018
• Support to the leishmaniasis global R&D and access initiative-Phase 2
• Total amount: USD 335,000

• Grant period: 2015-2017
• Support to the DNDi”s Demonstration Projects on leishmaniasis (VL; CL)
• Total amount: EUR 2,3 million
• Link to press release

ITALY

Region of Tuscany

 www.regione.toscana.it

• Grant period: 2007-2008
• Support to the development of SSG&PM (Paromomycin project) and capacity strengthening for visceral leishmaniasis
• Total amount: EUR 200,000

JAPAN

Global Health Innovative Technology Fund (GHIT Fund)

www.ghitfund.org

• Grant period: 2018-2020
• Support to preclinical development and phase I activities on a selected aminopyrazole compound for visceral leishmaniasis
• Total amount: JPY 604,775,700
• Link to press release

Grant period: 2018-2020
• Support to screening activities for Natural Products
• Total amount: JPY 11,900,000
• Link to announcement

Grant period: 2018-2020
• Support to NTD Drug Discovery Booster III
• Total amount: JPY 149,832,868

• Grant period: 2017-2019
• Support to mycetoma treatment, fosravuconazole clinical trial
• Total amount: JPY 252,621,720
• Link to announcement

• Grant period: 2017-2019
• Support to target bromodomains for novel anti-parasitic mechanisms of action for malaria, Chagas disease, leishmaniasis, and cryptosporidiosis
• Total amount: JPY 98,243,600
• Link to announcement

• Grant period: 2017-2019
• Support to DNDi preclinical development of CpG D35 for combined treatment of cutaneous leishmaniasis
• Total amount: JPY 491,867,214
• Link to announcement

• Grant period: 2017-2018
• Support to the Drug Discovery Booster II
• Total amount: JPY 54,944,748
• Link to announcement

• Grant period: 2017-2018
• Support for identification of lead compounds for visceral leishmaniasis and Chagas disease
• Total amount: JPY 78,000,000
• Link to announcement and press release

• Grant period: 2016-2017
• Support to DNDi preclinical efficacy of CpG D35 combination therapy for treatment of complicated cutaneous leishmaniasis
• Total amount: JPY 68,771,551
• Link to announcement

• Grant period: 2015-2017
• Support to lead optimization for visceral leishmaniasis
• Total amount: JPY 402,255,299
• Link to announcement

• Grant period: 2015-2017
• Support to the Drug Discovery Booster
• Total amount: JPY 79,543,796
• Link to press release

• Grant period: 2014-2018
• Support to DNDi Chagas disease programme (E1224 combination study & benznidazole)
• Total amount: JPY 384,089,264

• Grant period: 2013-2017
• Support to screening activities
• Total amount: JPY 24,338,495

LUXEMBOURG

Grand Duchy of Luxembourg

www.luxembourg.public.lu

• Grant period: 2017-2018
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: EUR 100,000
• Link to press release

MALAYSIA

Ministry of Health

www.moh.gov.my

• Support period:  2016-2018
• Support to DNDi initiative
• Collaborative funding

NORWAY

Norwegian Agency for Development Cooperation (Norad), Norwegian Ministry of Foreign Affairs

www.norad.no

• Grant period: 2013-2017
• Support to DNDi’s disease programme for human African trypanosomiasis
• Total amount: NOK 22 million
• Link to press release

SOUTH AFRICA

South African Medical Research Council (SAMRC)

www.samrc.ac.za

• Grant period: 2017-2019
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: R 10,000,000
• Link to press releases: May 2016 / September 2017 

SPAIN

Spanish Agency for International Development Cooperation (AECID)

www.aecid.es

• Grant period: 2007-2012
• Support to DNDi initiative
• Total amount: EUR 12 million

SWITZERLAND

Federal Office of Public Health (FOPH)

www.bag.admin.ch

• Grant period: 2017-2019
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: CHF 500,000
• Link to press release

• Grant period: 2016-2017
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: CHF 360,000
• Link to press release

Republic and Canton of Geneva, International Solidarity Office

www.ge.ch

• Grant period: 2016-2018
• Support to HAT (human African trypanosomiasis) activities
• Total amount: CHF 480,000

• Grant period: 2013-2015
• Support to  HAT (human African trypanosomiasis) activities
• Total amount: CHF 500,000

• Grant period: 2010-2012
• Support to the implementation of NECT (NECT-Field project) for human African trypanosomiasis
• Total amount: CHF 600,000

• Grant period: 2004-2009
• Support to the development of SSG&PM (paromomycin project) for visceral leishmaniasis
• Total amount: CHF 1 million

Swiss Agency for Development and Cooperation (SDC)

www.eda.admin.ch

• Grant period: 2017-2020
• Support to DND iinitiative
• Total amount: CHF 8 million

• Grant period: 2017-2018
• Support to an innovative oral combination treatment for visceral leishmaniasis
• Total amount: CHF 500,000

• Grant period: 2013-2016
• Support to DNDi initiative
• Total amount: CHF 8 million
• Link to press release

• Grant period: 2012-2013
• Support to DNDi Malaria programme
• Total amount: CHF 900,000

• Grant period: 2010-2012
• Support to DNDi initiative
• Total amount: CHF 4 million
• Link to press release

• Grant period: 2005-2006
• Support to DNDi Malaria programme
• Total amount: CHF 120,000

THAILAND

National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology

http://www.nstda.or.th

• Support period: 2017
• Support to DNDi initiative
• Collaborative funding

THE NETHERLANDS

Dutch Ministry of Foreign Affairs (DGIS)

www.minbuza.nl/en/ministry

• Grant period: 2015-2020
• Support to DNDI’s disease programmes for human African trypanosomiasis (HAT), Chagas disease, leishmaniasis and mycetoma (from screening to clinical studies and implementation for new and improved products).
• Total amount: EUR 16 million

• Grant period: 2011-2014
• Support to DNDi’s disease programmes for human African trypanosomiasis (HAT), Chagas disease, and leishmaniasis (from screening to clinical studies and implementation for new and improved products).
• Total amount: EUR 14 million
• Link to press release

• Grant period: 2006-2010
• Support to DNDi malaria project (FACT)
• Total amount: EUR 2.9 million

Dutch Ministry of Health, Welfare and Sport (VWS)

www.government.nl

• Grant period: 2017-2018
• Support to Global Antibiotic Research and Development Partnership (GARDP)
• Total amount: EUR 2.5 million
• Link to press releases: May 2016 / September 2017 

UNITED KINGDOM

UK aid

www.dfid.gov.uk

• Grant period: 2017-2021
• Support to DNDi initiative
• Total amount: GBP 52 million

• Grant period: 2013-2018
• Support to DNDi initiative
• Total amount: GBP 30 million
• Link to press release

• Grant period: 2015
• Support to DNDi initiative
• Total amount: GBP 3 million

• Grant period: 2015
• Support to DNDi initiative
• Total amount: GBP 3.05 million

• Grant period: 2014
• Support to DNDi initiative
• Total amount: GBP 3 million

• Grant period: 2009-2013
• Support to DNDi initiative
• Total amount: GBP 24.9 million
• Link to press release

• Grant period: 2006-2008
• Support to DNDi initiative
• Total amount: GBP 6.5 million
• Link to press release

USA

National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)

www.nih.gov

• Grant period: 2010-2013
• Support to preclinical activities (K777 project) for Chagas disease
• Total amount: USD 1.2 million

• Grant period: 2007-2012
• Support to Amphotericin B Polymer project for visceral leishmaniasis
• Total amount: USD 1.5 million
• Link to press release

United States Agency for International Development (USAID) (via the 4th Sector Health Project implemented by Abt Associates, Inc.)

www.usaid.gov

• Grant period: 2014-2019
• Support to the DNDi”s portfolio on filarial diseases
• Total amount: USD 10 million
• Link to press release

 


PRIVATE DONORS

BRAZIL

Médecins Sans Frontières (Doctors without Borders)

www.msf.org.br

• Grant period: 2011-2012
• Total amount: R$ 1 million
• Support to the development and registration of the paediatric dosage form of benznidazole for Chagas disease

INTERNATIONAL

FIND

www.finddx.org

• Grant period: 2018-2020
• Total amount: 924,580 USD (Supported by Unitaid unitaid.eu)
• Support for simplification and decentralization of HCV testing and treatment in Malaysia

Médecins Sans Frontières (Doctors without Borders)

www.msf.org

• Grant period: 2014-2018
• Total amount: EUR 600,000
• Support to DNDi initiative and Global Antibiotic Research and Development Partnership (GARDP) from four Operating Centers: France, Japan, Australia, USA)

• Grant period: 2014-2018
• Total amount: EUR 20 million
• Support to DNDi initiative

• Grant period: 2009-2013
• Total amount: EUR 18.4 million
• Support to DNDi initiative

• Grant period: 2003-2008
• Total amount: EUR 25 million
• Support to DNDi initiative
• Link to press release

ITALY

Médecins Sans Frontières (Doctors without Borders)

www.medicisenzafrontiere.it

• Grant period: 2010-2011
• Total amount: EUR 600,000
• Support to the development and registration of the paediatric dosage form of benznidazole for Chagas disease
• Link to press release

• Grant period: 2009
• Total amount: EUR 100,000
• Support to DNDi malaria project (FACT) – study in Liberia with ASAQ
• Link to press release

NORWAY

Médecins Sans Frontières (Doctors without Borders)

https://legerutengrenser.no/

• Grant period: 2011-2013
• Total amount: EUR 1,135,000
• Support to R&D for paediatric HIV programme

• Grant period: 2010
• Total amount: EUR 165,000
• Support to R&D opportunities for filarial diseases and paediatric HIV programmes

UNITED KINGDOM

Wellcome Trust

www.wellcome.ac.uk

• Grant period: 2012-2017
• Total amount: USD 3,000,000 + USD 85,182 as supplemental funding + USD 494,631 as additional funding
• Support to a study to validate PCR and other biomarkers for Chagas disease
• Link to press release

• Grant period: 2011-2014
• Total amount: EUR 1,999,801
• Support to the Phase II clinical trial of E1224 for Chagas disease
• Link to press release

USA

Bill & Melinda Gates Foundation

www.gatesfoundation.org

• Grant period: 2015-2019
• Total amount: USD 60 million
• Portfolio funding for human African trypanosomiasis (HAT), filarial diseases and visceral leishmaniasis
• Supplemental grant for HAT (2017-2019): USD 4.8 million
• Link to press release

• Grant period: 2014-2016
• Total amount: USD 1 million
• Support to DNDi activities through the “Innovative Fund Award”

• Grant period: 2013-2015
• Total amount: USD 2.3 million
• Support to identify new drug candidate for filarial diseases (supplemental grant to the grant to support screening for NTDs)

• Grant period: 2011-2015
• Total amount: USD 9 million
• Support to the adoption and implementation of new treatment options for visceral leishmaniasis in Asia
• Link to press release

• Grant period: 2011-2014
• Total amount: USD 4.3 million
• Support to the pre-clinical development of a macrofilaricidal drug candidate (flubendazole) for filarial diseases
• Link to press release

• Grant period: 2011-2013
• Total amount: USD 2 million
• Support to screening for neglected tropical diseases

• Grant period: 2009-2014
• Total amount: USD 19.4 million
• Support to the clinical development of fexinidazole for human African trypanosomiasis
• Link to press release

• Grant period: 2007-2012
• Total amount: USD 27.2 million
• Support to lead optimization, preclinical and start of clinical activities for human African trypanosomiasis/visceral leishmaniasis
• Link to press release

 


PRIVATE FOUNDATIONS AND PRIVATE INDIVIDUAL DONORS

BRAZIL

Associação Bem-Te-Vi Diversidade

www.associacaobemtevi.org.br

• Grant period: 2017
• Total amount: BRL 1.5 million
• Support to DNDi’s Chagas disease and leishmaniasis programs in Latin America

• Grant period: 2016
• Total amount: BRL 1.5 million
• Support to DNDi’s Chagas disease and leishmaniasis programs in Latin America

LIECHTENSTEIN

Medicor Foundation

www.medicor.li

• Grant period: 2017-2019
• Total amount: EUR 600,000
• Support to VL programmes in East Africa

• Grant period: 2009-2013
• Total amount: USD 2.3 million
• Support to VL programmes in Africa

• Grant period: 2007
• Total amount: EUR 650,000
• Support to VL programmes in Africa

MEXICO

Carlos Slim Foundation through the Carlos Slim Health Award

www.salud.carlosslim.org

• Grant period: 2013
• Total amount: USD 100,000
• Support to Chagas programme
• Link to press release

SPAIN

BBVA Foundation (through the “Frontiers of Knowledge Award in Development Cooperation”)

www.bbva.com

• Grant period: 2012
• Total amount: EUR 400,000
• Support to DNDi initiative
• Link to press release

SWITZERLAND

Fondation Anne Maurer-Cecchini

• 2018 award
• Total amount: CHF 20,000
• Support to DNDi initiative

UBS Optimus Foundation

www.ubs.com/optimus

• Grant period: 2013-2016
• Total amount: CHF 750,000
• Support to Paediatric HIV – “Developing drug granules for children with HIV and TB”

• Grant period: 2006-2009
• Total amount: CHF 1,080,000
• Drug development for Chagas disease and Human African Trypanosomiasis

• Grant period: 2005
• Total amount: CHF 170,000
• Drug development for Chagas disease and Human African Trypanoyomiasis

USA

Stavros Niarchos Foundation

www.snf.org

• Grant period: 2018
• Total amount: USD 500,000
• Support to the sustainable elimination of African sleeping sickness through the development and delivery of breakthrough treatments for neglected patients

The Rockefeller Foundation (through the “Next Century Innovators Award”)

www.rockefellerfoundation.org/

• Grant period: 2013
• Total amount: USD 100,000
• Support to DNDi initiative
• Link to press release

 

 

Other private individuals and foundations

Bennett Shapiro and Fredericka Foster, USA

Brian Mercer Charitable Trust, UK

Charina Endowment Fund, USA

Clifford N. Burnstein & Sabra C. Turnbull, USA

craigslist Charitable Fund, USA

David and Lisa U’Prichard, USA

Family of Richard Rockefeller, USA

Fondation André & Cyprien, Switzerland

Fondation ARPE, Switzerland

Fondation de bienfaisance du groupe Pictet, Switzerland

Fondation Pro Victimis, Switzerland

George H. Stout, USA

Goldman, Sachs & Co., USA

Guy’s, King’s and St Thomas’, Giving Week, UK

Harlan and Sally Weisman, USA

Jeff Nelson, USA

Leopold Bachmann Foundation, Switzerland

Dr Margaret Golden, USA

Marsha Fanucci, USA

Meena and Liaquat Ahamed, USA

P B & K Family Foundation, USA

Rockefeller Brothers Fund, USA

Ronald L. Thatcher, USA

Sandoz Family Foundation, Switzerland

Sasakawa Peace Foundation, Japan

Starr International Foundation, Switzerland

Steve Rabin and Jonathan Winslow, USA

The Broder Family Foundation, USA

The Peter and Carmen Lucia Buck Foundation, USA

The Robin O’Brien Fund, USA

The Stainman Family Foundation, USA

Zegar Family Fund, USA

Other private foundations and individuals who would like to remain anonymous

top of the page

 

Last update: October 2018